Literature DB >> 11855843

Atrophic change of rat salivary gland during adenovirus-induced hyperleptinemia.

Moritake Higa1, Michio Shimabukuro, Mari Fukuchi, Ichiro Komiya, Nobuyuki Takasu.   

Abstract

Sustained hyperleptinemia in normal rats induced by infusing a recombinant adenovirus containing the rat leptin cDNA (AdCMV-leptin) exhibited a remarkable reduction in food intake (AdCMV-leptin, 9.3 +/- 2.6 vs untreated, 20.6 +/- 1.0 g/day) and ablated body fat without any significant changes in wet weight of liver and left ventricle. In those hyperleptinemic rats, we found a 52% reduction in wet weight of salivary gland compared with that in the pair-fed AdCMV-beta-gal-treated rats, which received a recombinant virus containing the beta-galactosidase gene (AdCMV-beta-gal) and were fed on the same amount of food as had been consumed by the AdCMV-leptin-treated group on the previous day. Microscopic examination with hematoxylin-eosin staining revealed that atrophic change was induced in both serous and mucous gland only in the AdCMV-leptin-treated group, but not in the pair-fed controls. Thus, the atrophic changes in hyperleptinemic rats were due to neither a decrease of food intake nor disuse of the salivary gland related with anorexia. Our data suggested that size of the salivary gland was controlled, at lease in part, by "non-anorexic" effect of leptin.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11855843     DOI: 10.1006/bbrc.2002.6501

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  1 in total

1.  The immunohistochemical peptidergic expression of leptin is associated with recurrence of malignancy in laryngeal squamous cell carcinoma.

Authors:  S Gallina; F Sireci; F Lorusso; D V DI Benedetto; R Speciale; D Marchese; C Costantino; G Napoli; V Tessitore; D Cucco; A Leone; G Bonaventura; M L Uzzo; G F Spatola
Journal:  Acta Otorhinolaryngol Ital       Date:  2015-02       Impact factor: 2.124

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.